Kate Lapane to Secondary Prevention
This is a "connection" page, showing publications Kate Lapane has written about Secondary Prevention.
Connection Strength
0.262
-
Alcusky M, Hume AL, Fisher M, Tjia J, Goldberg RJ, McManus DD, Lapane KL. Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs Aging. 2018 12; 35(12):1089-1098.
Score: 0.155
-
Lapane KL, Hughes CM. Did the introduction of a prospective payment system for nursing home stays reduce the likelihood of pharmacological management of secondary ischaemic stroke? Drugs Aging. 2006; 23(1):61-9.
Score: 0.063
-
Chen HY, Saczynski JS, Lapane KL, Kiefe CI, Goldberg RJ. Adherence to evidence-based secondary prevention pharmacotherapy in patients after an acute coronary syndrome: A systematic review. Heart Lung. 2015 Jul-Aug; 44(4):299-308.
Score: 0.030
-
Christian JB, Lapane KL, Toppa RS. Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents. Stroke. 2003 Nov; 34(11):2693-7.
Score: 0.014